Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

Abstract Background Elderly patients represent a major fraction of non-small cell lung cancer (NSCLC) patients in routine clinical practice, but they are still underrepresented in clinical trials. In particular, data regarding efficacy and safety in frail or elderly patients with respect to immunoth...

Full description

Bibliographic Details
Main Authors: Jonas Kuon, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Albrecht Stenzinger, Miriam Blasi, Farastuk Bozorgmehr, Martin Maenz, Meinhard Kieser, Marc Schneider, Michael Thomas
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Trials
Subjects:
Lung cancer
Durvalumab
PD-L1
Elderly
Frail
CARG
Online Access:http://link.springer.com/article/10.1186/s13063-020-04280-8

Internet

http://link.springer.com/article/10.1186/s13063-020-04280-8

Similar Items